La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Mangold Fondkommission Bilan de santé

Santé financière contrôle des critères 6/6

Mangold Fondkommission possède un total de capitaux propres de SEK197.4M et une dette totale de SEK0.0, ce qui porte son ratio d'endettement à 0%. Son actif total et son passif total sont SEK1.3B et de SEK1.1B.

Informations clés

Ratio d'endettement

SEK 0

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	SEK 487.80m
Fonds propres	SEK 197.40m
Total du passif	SEK 1.09b
Total des actifs	SEK 1.28b

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Is Now The Time To Put Mangold Fondkommission (STO:MANG) On Your Watchlist?

May 31

With EPS Growth And More, Mangold Fondkommission (STO:MANG) Is Interesting

Feb 13

I Ran A Stock Scan For Earnings Growth And Mangold Fondkommission (STO:MANG) Passed With Ease

Oct 15

Could The Mangold Fondkommission AB (STO:MANG) Ownership Structure Tell Us Something Useful?

Mar 11

How Much Are Mangold Fondkommission AB (STO:MANG) Insiders Taking Off The Table?

Feb 22

Why Mangold Fondkommission AB (STO:MANG) Is A Top Dividend Stock

Feb 01

Here's Why I Think Mangold Fondkommission (STO:MANG) Might Deserve Your Attention Today

Jan 06

Introducing Mangold Fondkommission (STO:MANG), The Stock That Zoomed 260% In The Last Three Years

Dec 11

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de MANG ( SEK1.0B ) dépassent ses passifs à court terme ( SEK995.3M ).

Passif à long terme: Les actifs à court terme de MANG ( SEK1.0B ) dépassent ses passifs à long terme ( SEK90.7M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: MANG est sans dette.

Réduire la dette: MANG n'a aucune dette par rapport à il y a 5 ans, lorsque son ratio d'endettement était 19.4%.

Couverture de la dette: MANG n'a pas de dette, elle n'a donc pas besoin d'être couverte par le flux de trésorerie opérationnel.

Couverture des intérêts: MANG n'a aucune dette, par conséquent la couverture des paiements d'intérêts n'est pas un problème.

Mangold Fondkommission Bilan de santé

Santé financière contrôle des critères 6/6

Informations clés

Mises à jour récentes de la santé financière

Recent updates

New minor risk - Market cap size

CEO & MD recently bought kr50k worth of stock

Chairman of the Board recently bought kr52k worth of stock

Chairman of the Board recently bought kr83k worth of stock

Chairman of the Board recently bought kr64k worth of stock

First quarter 2024 earnings released: EPS: kr2.13 (vs kr17.54 loss in 1Q 2023)

Chairman of the Board recently bought kr142k worth of stock

Upcoming dividend of kr20.00 per share

First quarter 2024 earnings released: EPS: kr2.13 (vs kr17.54 loss in 1Q 2023)

Full year 2023 earnings released: kr22.19 loss per share (vs kr44.55 loss in FY 2022)

New minor risk - Share price stability

Chairman of the Board recently bought kr161k worth of stock

Full year 2023 earnings released: kr22.23 loss per share (vs kr44.55 loss in FY 2022)

Chairman of the Board recently bought kr57k worth of stock

Chairman of the Board recently bought kr105k worth of stock

Chairman of the Board recently bought kr201k worth of stock

Chairman of the Board recently bought kr125k worth of stock

Chairman of the Board recently bought kr95k worth of stock

Chairman of the Board recently bought kr1.3m worth of stock

New major risk - Revenue and earnings growth

Third quarter 2023 earnings released: kr35.70 loss per share (vs kr13.43 profit in 3Q 2022)

New major risk - Share price stability

Chief Financial Officer recently bought kr838k worth of stock

Chairman of the Board recently bought kr112k worth of stock

Head of Investment Banking recently bought kr1.0m worth of stock

New minor risk - Share price stability

Second quarter 2023 earnings released: kr4.71 loss per share (vs kr26.37 loss in 2Q 2022)

Chief Financial Officer recently bought kr379k worth of stock

Chairman of the Board recently bought kr125k worth of stock

Chairman of the Board recently bought kr147k worth of stock

Chairman of the Board recently bought kr616k worth of stock

First quarter 2023 earnings released: kr17.54 loss per share (vs kr32.25 loss in 1Q 2022)

Chairman of the Board recently sold kr1.0m worth of stock

CEO & MD recently bought kr66k worth of stock

CEO & MD exercised options to buy kr1.7m worth of stock.

Full year 2022 earnings released: kr44.45 loss per share (vs kr247 profit in FY 2021)

Third quarter 2022 earnings released: EPS: kr13.43 (vs kr132 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: kr26.37 loss per share (vs kr50.33 profit in 2Q 2021)

Investor sentiment deteriorated over the past week

Is Now The Time To Put Mangold Fondkommission (STO:MANG) On Your Watchlist?

Investor sentiment improved over the past week

Insufficient new directors

CEO & MD recently bought kr540k worth of stock

First quarter 2022 earnings released: kr32.25 loss per share (vs kr33.99 profit in 1Q 2021)

Upcoming dividend of kr49.00 per share

CEO & MD recently bought kr76k worth of stock

CEO & MD recently bought kr181k worth of stock

Investor sentiment improved over the past week

With EPS Growth And More, Mangold Fondkommission (STO:MANG) Is Interesting

Insufficient new directors

Head of Investment Banking recently bought kr117k worth of stock

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS kr132 (vs kr22.10 in 3Q 2020)

Investor sentiment improved over the past week

I Ran A Stock Scan For Earnings Growth And Mangold Fondkommission (STO:MANG) Passed With Ease

Investor sentiment improved over the past week

Chairman of the Board recently sold kr271k worth of stock

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS kr50.40 (vs kr20.72 in 2Q 2020)

Do Mangold Fondkommission's (STO:MANG) Earnings Warrant Your Attention?

Investor sentiment improved over the past week

Is Mangold Fondkommission AB (STO:MANG) A Smart Pick For Income Investors?

First quarter 2021 earnings released: EPS kr33.99 (vs kr0.87 in 1Q 2020)

Here's Why We Think Mangold Fondkommission (STO:MANG) Is Well Worth Watching

Upcoming dividend of kr17.30 per share

Have Insiders Sold Mangold Fondkommission AB (STO:MANG) Shares Recently?

Head of Private Banking recently sold kr221k worth of stock

Investor sentiment improved over the past week

Could The Mangold Fondkommission AB (STO:MANG) Ownership Structure Tell Us Something Useful?

New 90-day high: kr1,930

How Much Are Mangold Fondkommission AB (STO:MANG) Insiders Taking Off The Table?